Clin2
NCT07324291Possibly a fitNot yet recruiting

Infection risk after stem cell transplant

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONCarbapenem-resistant Enterobacterales

Part of Blood & lymphatic, Infections clinical trials.

This study looks at how common a certain type of drug-resistant bacteria is in the anal area after a stem cell transplant. It aims to see if these bacteria increase the risk of infection.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have received a stem cell transplant from a donor.
  • Your transplanted cells have successfully started working in your body (engraftment).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06912347Enrolling by invitation
Herbal therapy to prevent infection after stem cell transplant

This trial tests whether a special herbal treatment applied to the skin can help prevent infections around the bottom that are caused by diarrhea after a stem cell transplant. It may be an option for people who are getting a transplant for the first time.

Shanghai, Shanghai Municipality
NCT07157670Not yet recruiting
Heart health study after stem cell transplant

This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.

NCT06704542Not yet recruiting
Glucose tolerance after stem cell transplant study

This study looks at blood sugar problems in people who received a stem cell transplant from a donor. It aims to understand how common these problems are and what might affect them.

Zhengzhou, Henan
NCT03357172Recruiting
Study immune changes after a stem cell transplant

This study looks at how the immune system changes after an allogeneic stem cell transplant (using a donor’s stem cells). It may help researchers understand what controls immune recovery and transplant-related complications.

Vandœuvre-lès-Nancy
NCT04623424Recruiting
Study gut bacteria during stem cell transplant

This study looks at changes in your gut bacteria (microbiome) around the time of stem cell transplant. The goal is to understand how these bacteria relate to transplant outcomes, which may help doctors improve care in the future.

Detroit, Michigan
NCT07379554Recruiting
Infection Risk Prediction After Transplant

This study is for people who have had a stem cell or solid organ transplant. It aims to predict who might get a serious infection and help doctors manage their care better.

Pavia, Lombardy

Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.